US 11866502
Anti-FGFR2 antibodies and methods of use thereof
granted A61KA61K2039/505A61K45/06
Quick answer
US patent 11866502 (Anti-FGFR2 antibodies and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 65
- CPC classes
- A61K, A61K2039/505, A61K45/06, A61K47/68033, A61K47/68037